Literature DB >> 16040978

Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells.

Sven Hammerschmidt1, Sonja Wolff, Andreas Hocke, Simone Rosseau, Ellruth Müller, Manfred Rohde.   

Abstract

The capsular polysaccharide of Streptococcus pneumoniae represents an important virulence factor and protects against phagocytosis. In this study the amount of capsular polysaccharide present on the bacterial surface during the infection process was illustrated by electron microscopic studies. After infection of A549 cells (type II pneumocytes) and HEp-2 epithelial cells a modified fixation method was used that allowed visualization of the state of capsule expression. This modified fixation procedure did not require the use of capsule-specific antibodies. Visualization of pneumococci in intimate contact and invading cells demonstrated that pneumococci were devoid of capsular polysaccharide. Pneumococci not in contact with the cells did not show alterations in capsular polysaccharide. After infection of the cells, invasive pneumococci of different strains and serotypes were recovered. Single colonies of these recovered pneumococci exhibited an up-to-10(5)-fold-enhanced capacity to adhere and an up-to-10(4)-fold-enhanced capacity to invade epithelial cells. Electron microscopic studies using a lysine-ruthenium red (LRR) fixation procedure or cryo-field emission scanning electron microscopy revealed a reduction in capsular material, as determined in detail for a serotype 3 pneumococcal strain. The amount of polysaccharide in the serotype 3 capsule was also determined after intranasal infection of mice. This study illustrates for the first time the phenotypic variation of the polysaccharide capsule in the initial phase of pneumococcal infections. The modified LRR fixation allowed monitoring of the state of capsule expression of pathogens during the infectious process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040978      PMCID: PMC1201225          DOI: 10.1128/IAI.73.8.4653-4667.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  Spontaneous sequence duplication within an open reading frame of the pneumococcal type 3 capsule locus causes high-frequency phase variation.

Authors:  R D Waite; J K Struthers; C G Dowson
Journal:  Mol Microbiol       Date:  2001-12       Impact factor: 3.501

2.  Spontaneous sequence duplications within capsule genes cap8E and tts control phase variation in Streptococcus pneumoniae serotypes 8 and 37.

Authors:  Richard D Waite; David W Penfold; J Keith Struthers; Christopher G Dowson
Journal:  Microbiology       Date:  2003-02       Impact factor: 2.777

3.  Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection.

Authors:  H M Schrager; J G Rheinwald; M R Wessels
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

4.  Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae.

Authors:  J O Kim; J N Weiser
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

Review 5.  Pathogenesis of pneumococcal infection.

Authors:  E I Tuomanen; R Austrian; H R Masure
Journal:  N Engl J Med       Date:  1995-05-11       Impact factor: 91.245

6.  Genetic and molecular characterization of capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 3.

Authors:  J P Dillard; J Yother
Journal:  Mol Microbiol       Date:  1994-06       Impact factor: 3.501

7.  Marker discrimination and mutagen-induced alterations in pneumococcal transformation.

Authors:  J G Tiraby; M S Fox
Journal:  Genetics       Date:  1974-07       Impact factor: 4.562

8.  Requirement for capsule in colonization by Streptococcus pneumoniae.

Authors:  A D Magee; J Yother
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

9.  The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo.

Authors:  A David Ogunniyi; Philippe Giammarinaro; James C Paton
Journal:  Microbiology       Date:  2002-07       Impact factor: 2.777

Review 10.  Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention.

Authors:  R Austrian
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr
View more
  163 in total

1.  Pneumococcal 6-phosphogluconate-dehydrogenase, a putative adhesin, induces protective immune response in mice.

Authors:  D Daniely; M Portnoi; M Shagan; A Porgador; N Givon-Lavi; E Ling; R Dagan; Y Mizrachi Nebenzahl
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Interleukin-1β regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial cells and macrophages.

Authors:  Helen M Marriott; Kate A Gascoyne; Ravi Gowda; Ian Geary; Martin J H Nicklin; Francesco Iannelli; Gianni Pozzi; Timothy J Mitchell; Moira K B Whyte; Ian Sabroe; David H Dockrell
Journal:  Infect Immun       Date:  2011-12-12       Impact factor: 3.441

3.  Membrane topology and DNA-binding ability of the Streptococcal CpsA protein.

Authors:  Brett R Hanson; Beth A Lowe; Melody N Neely
Journal:  J Bacteriol       Date:  2010-11-19       Impact factor: 3.490

4.  Impact of glutamine transporters on pneumococcal fitness under infection-related conditions.

Authors:  Tobias Härtel; Matthias Klein; Uwe Koedel; Manfred Rohde; Lothar Petruschka; Sven Hammerschmidt
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

5.  Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo.

Authors:  Laura R Marks; G Iyer Parameswaran; Anders P Hakansson
Journal:  Infect Immun       Date:  2012-05-29       Impact factor: 3.441

6.  Distribution and invasiveness of Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic selection pressure, from 2001 to 2004.

Authors:  Andreas Kronenberg; Phillip Zucs; Sara Droz; Kathrin Mühlemann
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

7.  Lysogeny of Streptococcus pneumoniae with MM1 phage: improved adherence and other phenotypic changes.

Authors:  Jutta M Loeffler; Vincent A Fischetti
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

8.  Interaction of factor H-binding protein of Streptococcus suis with globotriaosylceramide promotes the development of meningitis.

Authors:  Decong Kong; Zhe Chen; Junping Wang; Qingyu Lv; Hua Jiang; Yuling Zheng; Maokai Xu; Xuyu Zhou; Huaijie Hao; Yongqiang Jiang
Journal:  Virulence       Date:  2017-04-12       Impact factor: 5.882

9.  Molecular mechanisms driving Streptococcus mitis entry into human gingival fibroblasts in presence of chitlac-nAg and saliva.

Authors:  M Di Giulio; V Di Valerio; D Bosco; E Marsich; A Cataldi; L Cellini; S Sancilio
Journal:  J Mater Sci Mater Med       Date:  2018-03-19       Impact factor: 3.896

10.  Position of O-Acetylation within the Capsular Repeat Unit Impacts the Biological Properties of Pneumococcal Serotypes 33A and 33F.

Authors:  Brady L Spencer; Jamil S Saad; Anukul T Shenoy; Carlos J Orihuela; Moon H Nahm
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.